32968070|t|Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development.
32968070|a|Innate immune signaling through the NLRP3 inflammasome is activated by multiple diabetes-related stressors, but whether targeting the inflammasome is beneficial for diabetes is still unclear. Nucleoside reverse-transcriptase inhibitors (NRTI), drugs approved to treat HIV-1 and hepatitis B infections, also block inflammasome activation. Here, we show, by analyzing five health insurance databases, that the adjusted risk of incident diabetes is 33% lower in patients with NRTI exposure among 128,861 patients with HIV-1 or hepatitis B (adjusted hazard ratio for NRTI exposure, 0.673; 95% confidence interval, 0.638 to 0.710; P < 0.0001; 95% prediction interval, 0.618 to 0.734). Meanwhile, an NRTI, lamivudine, improves insulin sensitivity and reduces inflammasome activation in diabetic and insulin resistance-induced human cells, as well as in mice fed with high-fat chow; mechanistically, inflammasome-activating short interspersed nuclear element (SINE) transcripts are elevated, whereas SINE-catabolizing DICER1 is reduced, in diabetic cells and mice. These data suggest the possibility of repurposing an approved class of drugs for prevention of diabetes.
32968070	30	35	NRTIs	Chemical	-
32968070	50	57	insulin	Gene	3630
32968070	83	98	type 2 diabetes	Disease	MESH:D003924
32968070	148	153	NLRP3	Gene	114548
32968070	192	200	diabetes	Disease	MESH:D003920
32968070	277	285	diabetes	Disease	MESH:D003920
32968070	304	347	Nucleoside reverse-transcriptase inhibitors	Chemical	-
32968070	349	353	NRTI	Chemical	-
32968070	380	385	HIV-1	Disease	MESH:D015658
32968070	390	412	hepatitis B infections	Disease	MESH:D006509
32968070	546	554	diabetes	Disease	MESH:D003920
32968070	571	579	patients	Species	9606
32968070	585	589	NRTI	Chemical	-
32968070	613	621	patients	Species	9606
32968070	627	632	HIV-1	Species	11676
32968070	636	647	hepatitis B	Species	
32968070	675	679	NRTI	Chemical	-
32968070	806	810	NRTI	Chemical	-
32968070	812	822	lamivudine	Chemical	MESH:D019259
32968070	833	840	insulin	Gene	3630
32968070	892	900	diabetic	Disease	MESH:D003920
32968070	905	923	insulin resistance	Disease	MESH:D007333
32968070	932	937	human	Species	9606
32968070	959	963	mice	Species	10090
32968070	1123	1129	DICER1	Gene	192119
32968070	1145	1153	diabetic	Disease	MESH:D003920
32968070	1164	1168	mice	Species	10090
32968070	1265	1273	diabetes	Disease	MESH:D003920
32968070	Positive_Correlation	MESH:D019259	3630
32968070	Negative_Correlation	MESH:D019259	MESH:D003920
32968070	Association	MESH:D003920	114548
32968070	Negative_Correlation	MESH:D019259	MESH:D007333
32968070	Association	MESH:D003920	192119

